Brigimadlin
- Generic Name
- Brigimadlin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H25Cl2FN4O3
- CAS Number
- 2095116-40-6
- Unique Ingredient Identifier
- 9A934ZAN94
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 50
- Registration Number
- NCT06619509
- Locations
- 🇪🇸
Fundación Jiménez Díaz, Madrid, Spain
🇪🇸Hospital Clínico San Carlos, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT06370871
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 240
- Registration Number
- NCT06058793
- Locations
- 🇯🇵
National Cancer Center Hospital, Tokyo, Chuo-ku, Japan
🇺🇸Precision NextGen Oncology, Beverly Hills, California, United States
🇺🇸Sarcoma Oncology Center, Santa Monica, California, United States
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-08-23
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 99
- Registration Number
- NCT05512377
- Locations
- 🇩🇪
Klinikum der Universität München AÖR, München, Germany
🇩🇪Universitätsklinikum Ulm, Ulm, Germany
🇺🇸Southern Cancer Center, Mobile, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath